BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11392459)

  • 1. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity.
    Pierce RC; Bari AA
    Rev Neurosci; 2001; 12(2):95-110. PubMed ID: 11392459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection.
    Castrén E
    Mol Neurobiol; 2004 Jun; 29(3):289-302. PubMed ID: 15181240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of quantal secretion by neurotrophic factors at developing motoneurons in Xenopus cell cultures.
    Liou JC; Yang RS; Fu WM
    J Physiol; 1997 Aug; 503 ( Pt 1)(Pt 1):129-39. PubMed ID: 9288681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
    Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
    J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotrophic factors and structural plasticity in addiction.
    Russo SJ; Mazei-Robison MS; Ables JL; Nestler EJ
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):73-82. PubMed ID: 18647613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural plasticity of the brain to psychostimulant use.
    Nyberg F
    Neuropharmacology; 2014 Dec; 87():115-24. PubMed ID: 25018041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo.
    Erickson JT; Brosenitsch TA; Katz DM
    J Neurosci; 2001 Jan; 21(2):581-9. PubMed ID: 11160437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity.
    Angelucci F; Ricci V; Spalletta G; Caltagirone C; Mathé AA; Bria P
    Int Rev Neurobiol; 2009; 88():1-24. PubMed ID: 19897072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in spinal GDNF, BDNF, and NT-3 expression after transient spinal cord ischemia in the rat.
    Tokumine J; Kakinohana O; Cizkova D; Smith DW; Marsala M
    J Neurosci Res; 2003 Nov; 74(4):552-61. PubMed ID: 14598299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic mechanisms in drug addiction.
    Bolaños CA; Nestler EJ
    Neuromolecular Med; 2004; 5(1):69-83. PubMed ID: 15001814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of neurotrophic factors in neurobiology of addiction and future directions.
    Koskela M; Bäck S; Võikar V; Richie CT; Domanskyi A; Harvey BK; Airavaara M
    Neurobiol Dis; 2017 Jan; 97(Pt B):189-200. PubMed ID: 27189755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum.
    Batchelor PE; Liberatore GT; Porritt MJ; Donnan GA; Howells DW
    Eur J Neurosci; 2000 Oct; 12(10):3462-8. PubMed ID: 11029615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuse.
    Nikulina EM; Johnston CE; Wang J; Hammer RP
    Neuroscience; 2014 Dec; 282():122-38. PubMed ID: 24875178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia.
    Angelucci F; Mathé AA; Aloe L
    Prog Brain Res; 2004; 146():151-65. PubMed ID: 14699963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of withdrawal from repeated amphetamine exposure in peri-puberty on neuroplasticity-related genes in mice.
    Calabrese F; Richetto J; Racagni G; Feldon J; Meyer U; Riva MA
    Neuroscience; 2013 Oct; 250():222-31. PubMed ID: 23872394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurotrophic factors and their role in the pathogenesis of affective disorders].
    Filuś JF; Rybakowski J
    Psychiatr Pol; 2005; 39(5):883-97. PubMed ID: 16358589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of psychostimulant-induced structural plasticity.
    Dietz DM; Dietz KC; Nestler EJ; Russo SJ
    Pharmacopsychiatry; 2009 May; 42 Suppl 1(Suppl 1):S69-78. PubMed ID: 19434558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation.
    Schoffelmeer AN; De Vries TJ; Wardeh G; van de Ven HW; Vanderschuren LJ
    J Neurosci; 2002 Apr; 22(8):3269-76. PubMed ID: 11943828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases.
    Mufson EJ; Kroin JS; Sendera TJ; Sobreviela T
    Prog Neurobiol; 1999 Feb; 57(4):451-84. PubMed ID: 10080385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring peripheral biomarkers in psychostimulant use: A systematic review on neurotrophins, stress-related hormones, oxidative stress molecules and genetic factors.
    Mancusi G; Miuli A; Santorelli M; Cavallotto C; Susini O; Pernaci G; Výborová E; Rosa I; d'Onofrio AM; Camardese G; Pettorruso M; Sensi SL; Martinotti G
    Behav Brain Res; 2024 Jul; 469():115046. PubMed ID: 38761859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.